Can CAPTURE be used to identify undiagnosed patients with mild-to-moderate COPD likely to benefit from treatment?

Nancy K Leidy1 Evidera, Patient-Centered Research, Bethesda, MD, USACorrespondence[email protected]

Fernando J Martinez2 Weill Cornell Medicine, Joan & Sanford Weill Department of Medicine, New York, NY, USA

Karen G Malley1 Evidera, Patient-Centered Research, Bethesda, MD, USA

David M Mannino3 University of Kentucky, Preventive Medicine & Environmental Health, Lexington, KY, USA

MeiLan K Han4 University of Michigan, Division of Pulmonary & Critical Care Medicine, Ann Arbor, MI, USA

Elizabeth D Bacci5 Evidera, Patient-Centered Research, Seattle, WA, USA

Randall W Brown6 University of Michigan, Department of Health Behavior & Health Education, School of Public Health, Ann Arbor, MI, USA

Julia F Houfek7 University of Nebraska Medical Center College of Nursing, Omaha, NE, USA

Wassim W Labaki4 University of Michigan, Division of Pulmonary & Critical Care Medicine, Ann Arbor, MI, USA

Barry J Make8 National Jewish Health, Department of Medicine, Division of Pulmonary, Critical Care & Sleep Medicine, Denver, CO, USA

Catherine A Meldrum4 University of Michigan, Division of Pulmonary & Critical Care Medicine, Ann Arbor, MI, USA

Wilson Quezada9 Columbia University Medical Center, Division of Pulmonary, Allergy, & Critical Care, New York, NY, USA

Stephen Rennard10 AstraZeneca, IMED Biotech Unit, Cambridge, UK & University of Nebraska Medical Center, Department of Medicine, Omaha, NE, USA

Byron Thomashow9 Columbia University Medical Center, Division of Pulmonary, Allergy, & Critical Care, New York, NY, USA

Barbara P Yawn11 University of Minnesota, Department of Family & Community Health, Minneapolis, MN & COPD Foundation, Miami, FL, USA

References